Bill Analyses and Ratings
Bill Information: S1102 – Residential care, assisted living
Rating: +1
Bill Summary:
Senate Bill 1102 substantially rewrites and modernizes the Idaho Residential Care or Assisted Living Act. It updates definitions, codifies procedures for licensing, inspection, complaint investigation, and enforcement, and expands resident rights. The bill establishes clearer timelines for complaint responses and plan-of-correction submissions and categorizes rule violations as either “core” or “non-core,” with appropriate penalties. It permits facilities to use nationally recognized accreditation in place of state inspections and includes provisions for negotiated rulemaking with industry stakeholders. It also repeals several outdated or redundant waiver and variance provisions in existing code and nullifies specific IDAPA administrative rules.
Significantly, the bill outlines detailed protections for residents, including the right to informed consent, access to medical records, privacy in care, and freedom from abuse, coercion, and inappropriate restraint. It creates a more transparent system for public accountability while preserving flexibility for care providers who meet independent accreditation standards.
Reason for Rating:
This bill aligns strongly with the Idaho Republican Party Platform in several key areas. It curtails bureaucratic overreach by replacing discretionary administrative rulemaking with clear, legislatively authorized procedures and negotiated rulemaking. It affirms the platform’s commitment to protecting the dignity and rights of Idaho’s elderly by expanding individual freedoms within residential care settings. By streamlining enforcement procedures, increasing transparency, and acknowledging private sector accreditation in lieu of state inspections, SB 1102 supports both limited government and market-friendly alternatives. These reforms strike a proper balance between accountability and autonomy in health and welfare regulation, earning it a score of +1.
Rating Breakdown
Overall Rating (1)
Legacy rating from 2025 analysis
